TransMedics Group, Inc.
TMDX
$133.81
-$8.12-5.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -30.33% | 35.92% | 274.54% | 62.64% | -65.43% |
| Total Depreciation and Amortization | -10.13% | 9.68% | 8.05% | 9.72% | 12.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.03% | 0.62% | -24.94% | 48.72% | -0.40% |
| Change in Net Operating Assets | -30.49% | 190.51% | -661.32% | 48.16% | -6,455.37% |
| Cash from Operations | -24.05% | 3,308.72% | -114.52% | 186.76% | -73.34% |
| Capital Expenditure | 15.99% | 66.44% | -98.72% | 71.77% | -102.85% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 15.99% | 66.44% | -98.72% | 71.51% | -100.99% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -46.69% | 134.11% | 155.31% | -84.91% | -26.12% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -48.64% | 134.11% | 155.31% | -84.91% | -26.12% |
| Foreign Exchange rate Adjustments | -98.89% | 125.98% | 152.11% | -277.98% | 722.58% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -27.46% | 441.16% | -504.32% | 120.08% | -360.55% |